Testing effectiveness (Phase 2)Study completedNCT00847522
What this trial is testing
Fluorescein for Lymphatic Mapping and Sentinel Lymph Node (SLN) Biopsy in Patients With Stage I and II Malignant Melanoma
Who this might be right for
Cancer
University of Utah 90